Fenben, also known as “Fen” is a common broad-spectrum anthelmintic (dewormer). It belongs to the family of benzimidazole carbamates, commonly called Benz (I coined it BZ). This family of drugs has been used safely for decades.
While some studies have found similarities between parasitic cells and cancer cells, there is no evidence to suggest that antiparasitic medications could cure cancer in humans. Sheila Singh, a veterinarian with McMaster University, explains why in this article.
Fenben cancer treatment has gained popularity in recent years due to a few anecdotal success stories. It has also been shown to be effective in preclinical studies. However, this repurposed drug has not yet been approved for use by governing bodies. Nevertheless, it can be used alongside standard of care treatments and offers an alternative way to treat certain cancers.
How does fenben cancer treatment work? This dewormer works by destroying the microtubules that support the structure of cancer cells. This prevents them from dividing and multiplying at a fast rate. It also boosts the production of p53, which is a cancer-killing gene. Additionally, fenben cancer treatment blocks the tumor’s access to sugar. Cancer cells metabolize sugar for energy and this can help them survive.
In one study, a team of researchers tested fenben cancer treatment on xenografts, which are human cancer cells implanted into mice for testing. They found that the fenbendazole reduced tumor growth, especially when it was combined with vitamins. Another benefit of this dewormer is that it is easy to administer and has very few side effects. fenben